Addition of bortezomib improves efficacy of thalidomide/dexamethasone in newly diagnosed patients with multiple myeloma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL LYMPHOMA & MYELOMA | 2008年 / 8卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [1] Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
    Zafar, Mir Sadaqat Hassan
    Khan, Afaq Ahmed
    Aggarwal, Shyam
    Bhargava, Manorama
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 58 - 60
  • [2] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [3] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma in Chinese patients
    Cai, Zhen
    Zheng, Weiyan
    Wei, Guoqing
    Ye, Xiujin
    He, Jingsong
    Li, Li
    Wu, Wenjun
    Lin, Maofang
    [J]. BLOOD, 2007, 110 (11) : 281B - 281B
  • [4] Bortezomib and thalidomide treatment of newly diagnosed patients with multiple myeloma - Efficacy and neurotoxicity.
    Borrello, Ivan
    Ferguson, Anna
    Huff, Carol Ann
    George, Shirley
    Biedryzcki, Barbara
    Cornblath, David
    Chaudhry, Vinay
    [J]. BLOOD, 2006, 108 (11) : 1006A - 1006A
  • [5] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Guangzhong Yang
    Wenming Chen
    Yin Wu
    [J]. Chinese Journal of Cancer Research, 2013, 25 (02) : 155 - 160
  • [6] Bortezomib, dexamethasone plus thalidomide for treatment of newly diagnosed multiple myeloma patients with or without renal impairment
    Yang, Guangzhong
    Chen, Wenming
    Wu, Yin
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (02) : 155 - 160
  • [7] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, Johnny
    O'Ceallaigh, Cathal
    Keane, Colm
    Otridge, Brian W.
    O'Gorman, Peter
    [J]. BLOOD, 2006, 108 (11) : 370B - 370B
  • [8] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
    McHugh, J
    Keane, C
    Otridge, BW
    Thornton, P
    O'Gorman, P
    [J]. BLOOD, 2005, 106 (11) : 380B - 380B
  • [9] Efficacy and safety of thalidomide and dexamethasone combination with or without cyclophosphamide in patients with newly diagnosed multiple myeloma
    Kim, Y.-K.
    Lee, J. J.
    Sohn, S. K.
    Shin, H. J.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Kim, D. H.
    Yang, D. H.
    Cho, S. H.
    Chung, I. J.
    Kim, H. J.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 411 - 412
  • [10] Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA)
    Roussel, Murielle
    Moreau, Philippe
    Hebraud, Benjamin
    Laribi, Kamel
    Jaccard, Arnaud
    Dib, Mamoun
    Slama, Borhane
    Dorvaux, Veronique
    Royer, Bruno
    Frenzel, Laurent
    Zweegman, Sonja
    Klein, Saskia K.
    Broijl, Annemiek
    Jie, Kon-Siong
    Wang, Jianping
    Vanquickelberghe, Veronique
    Boer, Carla de
    Kampfenkel, Tobias
    Gries, Katharine S.
    Fastenau, John
    Sonneveld, Pieter
    [J]. LANCET HAEMATOLOGY, 2020, 7 (12): : E874 - E883
12345